Enhancing adoptive cancer immunotherapy with VÎ³2VÎ´2 T cells through pulse zoledronate stimulation.

Nada, Mohanad H; Wang, Hong; Workalemahu, Grefachew; Tanaka, Yoshimasa; Morita, Craig T

Nada, Mohanad H; Wang, Hong; Workalemahu, Grefachew; Tanaka, Yoshimasa; Morita, Craig T.

Afiliación

Nada MH; Division of Immunology, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52242 USA.
Wang H; Department of Veterans Affairs, Iowa City Health Care System, Iowa City, IA 52246 USA.
Workalemahu G; Interdisciplinary Graduate Program in Immunology, University of Iowa Carver College of Medicine, Iowa City, IA 52242 USA.
Tanaka Y; Department of Pathology, College of Medicine, Tikrit University, Tikrit, Iraq.
Morita CT; Division of Immunology, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52242 USA.

J Immunother Cancer ; 5: 9, 2017.

Article en En | MEDLINE | ID: mdl-28239463

Asunto(s)

Difosfonatos/farmacología; Imidazoles/farmacología; Inmunoterapia Adoptiva; Interleucina-15/farmacología; Interleucina-2/farmacología; Linfocitos Intraepiteliales/trasplante; Neoplasias/terapia; Adulto; Animales; Línea Celular Tumoral; Femenino; Humanos; Linfocitos Intraepiteliales/efectos de los fármacos; Ratones; Neoplasias/patología; Carga Tumoral/efectos de los fármacos; Ácido Zoledrónico

Palabras clave

Adoptive cancer immunotherapy; Bisphosphonate; Human; IL-15; IL-2; Memory T cell subsets; Prostate cancer; VÎ³2VÎ´2 T cells; Zoledronate; Î³Î´ T cells

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Interleucina-2 / Interleucina-15 / Difosfonatos / Linfocitos Intraepiteliales / Imidazoles / Neoplasias Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Animals / Female / Humans Idioma: En Revista: J Immunother Cancer Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google